International Journal of Molecular Sciences · 2020 · 10 citations · 66 references
MedicineNeurosciencePharmacologyNeurochemistryNeurodegenerationNeuropharmacologyAntipsychotic PharmacologyAnxiolytic PharmacologyAnxiolytic PharmacotherapyDopaminergic PharmacologyNeuroprotectionNeuroprotective PharmacologyAntipsychotic ActionDeferred TreatmentMotor Behavior AssessmentParkinson Disease LesioningParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyParkinson’s Disease TreatmentStriatal Dopamine Function
Previously, we demonstrated that the immediate administration of multitarget anxiolytic afobazole slows down the progression of neuronal damage in a 6-hydroxidodamine (6-OHDA) model of Parkinson's disease due to the activation of chaperone Sigma1R. The aim of the present study is to evaluate the therapeutic potential of deferred afobazole administration in this model. Male ICR mice received a unilateral 6-OHDA lesion of the striatum. Fourteen days after the surgery, mice were treated with afobazole, selective Sigma1R agonist PRE-084, selective Sigma1R antagonist BD-1047, and a combination of BD-1047 with afobazole or PRE-084 for another 14 days. The deferred administration of afobazole restored the intrastriatal dopamine content in the 6-OHDA-lesioned striatum and facilitated motor behavior in rotarod tests. The action of afobazole accorded with the effect of Sigma1R selective agonist PRE-084 and was blocked by Sigma1R selective antagonist BD-1047. The present study illustrates the Sigma1R-dependent effects of afobazole in a 6-OHDA model of Parkinson's disease and reveals the therapeutic potential of Sigma1R agonists in treatment of the condition.
66
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Martin D. Bootman, Ludwig Missiaen, Jan B. Parys et al. · Biochemical Journal · 1995 · 5.1K citations
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner, Roberto Jappelli, Samir K. Maji et al. · Proceedings of the National Academy of Sciences · 2011 · 1.5K citations · Full text
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Jeffrey H. Kordower, C. Warren Olanow, Hemraj B. Dodiya et al. · Brain · 2013 · 1.3K citations · Full text
H. Sauer, Wolfgang H. Oertel · Neuroscience · 1994 · 795 citations